Harwood Feffer LLP Announces Investigation of CytRx Corporation

NEW YORK, March 14, 2014 /PRNewswire/ -- Harwood Feffer LLP (www.hfesq.com) is investigating potential claims against CytRx Corporation ("CytRx" or the "Company") (NASDAQ: CYTR) concerning whether it has violated the federal securities laws.

On March 13, 2014, a media report stated that the Company had hired an entity to promote CytRx stock that published a number of articles on the internet without disclosing that the Company had paid for the positive reporting.  At the same time, CytRx insiders were selling $86 million of new equity to investors.

If you own CytRx's shares and wish to discuss this matter with us, or have any questions concerning your rights and interests with regard to this matter, please contact:

Robert I. Harwood, Esq.
Daniella Quitt, Esq.
Benjamin I. Sachs-Michaels, Esq.
Harwood Feffer LLP
488 Madison Avenue
New York, New York 10022
Phone Numbers: (877) 935-7400 
                           (212)935-7400
Email:  bsachsmichaels@hfesq.com 
Website:   http://www.hfesq.com

Harwood Feffer has been representing individual and institutional investors for many years, serving as lead counsel in numerous cases in federal and state courts. Please visit the Harwood Feffer LLP website (http://www.hfesq.com) for more information about the firm.

Attorney Advertising. © 2014 Harwood Feffer LLP. The law firm responsible for this advertisement is Harwood Feffer LLP (www.hfesq.com). Prior results do not guarantee or predict a similar outcome with respect to any future matter.

Logo - http://photos.prnewswire.com/prnh/20120215/MM54604LOGO

SOURCE Harwood Feffer LLP



RELATED LINKS
http://www.hfesq.com

More by this Source


Custom Packages

Browse our custom packages or build your own to meet your unique communications needs.

Start today.

 

PR Newswire Membership

Fill out a PR Newswire membership form or contact us at (888) 776-0942.

Learn about PR Newswire services

Request more information about PR Newswire products and services or call us at (888) 776-0942.